Chemours (NYSE:CC) Stock Price Down 5.7% – Should You Sell?

Posted by Brenda Bartman on Jul 8th, 2026

The Chemours Company (NYSE:CC – Get Free Report)’s share price traded down 5.7% during mid-day trading on Monday . The stock traded as low as $17.89 and last traded at $17.9240. 1,482,750 shares changed hands during trading, a decline of 53% from the average session volume of 3,142,536 shares. The stock had previously closed at $19.01.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on CC. Truist Financial upped their price objective on shares of Chemours from $27.00 to $30.00 and gave the stock a “buy” rating in a research report on Tuesday, April 28th. Alembic Global Advisors reaffirmed an “overweight” rating and set a $30.00 target price on shares of Chemours in a research note on Wednesday, May 13th. Zacks Research upgraded shares of Chemours from a “strong sell” rating to a “hold” rating in a report on Friday, April 24th. Mizuho dropped their price target on Chemours from $30.00 to $25.00 and set an “outperform” rating for the company in a research note on Wednesday, July 1st. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Chemours in a report on Monday, April 20th. Six research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Chemours presently has a consensus rating of “Hold” and a consensus price target of $24.10.

Check Out Our Latest Analysis on CC

Chemours Price Performance

The company has a quick ratio of 0.87, a current ratio of 1.82 and a debt-to-equity ratio of 18.98. The stock has a market cap of $2.77 billion, a P/E ratio of -6.98 and a beta of 1.41. The company’s 50 day moving average price is $22.23 and its 200-day moving average price is $19.39.

Chemours (NYSE:CC – Get Free Report) last announced its earnings results on Tuesday, May 5th. The specialty chemicals company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.10. The business had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.40 billion. Chemours had a positive return on equity of 52.49% and a negative net margin of 6.82%.Chemours’s revenue for the quarter was up 1.0% compared to the same quarter last year. During the same period last year, the company earned $0.13 EPS. As a group, sell-side analysts expect that The Chemours Company will post 1.16 earnings per share for the current year.

Chemours Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Sunday, May 17th were given a $0.0875 dividend. The ex-dividend date was Friday, May 15th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 1.9%. Chemours’s payout ratio is -13.26%.

Hedge Funds Weigh In On Chemours

Hedge funds have recently bought and sold shares of the company. Atlas Capital Advisors Inc. acquired a new stake in Chemours during the 4th quarter worth about $26,000. Aster Capital Management DIFC Ltd acquired a new position in shares of Chemours in the 4th quarter valued at about $28,000. Covestor Ltd boosted its position in shares of Chemours by 204.7% during the 4th quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock valued at $31,000 after purchasing an additional 1,748 shares in the last quarter. Eurizon Capital SGR S.p.A. bought a new stake in shares of Chemours during the 4th quarter valued at about $31,000. Finally, Rothschild Investment LLC grew its stake in Chemours by 87.0% during the fourth quarter. Rothschild Investment LLC now owns 2,698 shares of the specialty chemicals company’s stock worth $32,000 after purchasing an additional 1,255 shares during the period. Institutional investors own 76.26% of the company’s stock.

About Chemours

(Get Free Report)

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.